Macrophage vesicles in antidiabetic drug action

Rinke Stienstra; Eric Kalkhoven

doi:10.1038/s42255-024-01030-x

Macrophage vesicles in antidiabetic drug action

Rinke Stienstra
, Eric Kalkhoven^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

Thiazolidinediones (TZDs) are potent insulin-sensitizing drugs, but their use is accompanied by adverse side-effects. Rohm et al. now report that TZD-stimulated macrophages release miR-690-containing vesicles that improve insulin sensitization and bypass unwanted side-effects.

Original language	English
Pages (from-to)	785-786
Number of pages	2
Journal	Nature metabolism
Volume	6
Issue number	5
DOIs	https://doi.org/10.1038/s42255-024-01030-x
Publication status	Published - May 2024

Access to Document

10.1038/s42255-024-01030-x

s42255-024-01030-xFinal published version, 905 KBLicence: Taverne

Cite this

@article{d2e6cf6c211847b48f2f92ed8456ddec,

title = "Macrophage vesicles in antidiabetic drug action",

abstract = "Thiazolidinediones (TZDs) are potent insulin-sensitizing drugs, but their use is accompanied by adverse side-effects. Rohm et al. now report that TZD-stimulated macrophages release miR-690-containing vesicles that improve insulin sensitization and bypass unwanted side-effects.",

author = "Rinke Stienstra and Eric Kalkhoven",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2024.",

year = "2024",

month = may,

doi = "10.1038/s42255-024-01030-x",

language = "English",

volume = "6",

pages = "785--786",

journal = "Nature metabolism",

publisher = "Nature Research",

number = "5",

}

TY - JOUR

T1 - Macrophage vesicles in antidiabetic drug action

AU - Stienstra, Rinke

AU - Kalkhoven, Eric

N1 - Publisher Copyright: © Springer Nature Limited 2024.

PY - 2024/5

Y1 - 2024/5

N2 - Thiazolidinediones (TZDs) are potent insulin-sensitizing drugs, but their use is accompanied by adverse side-effects. Rohm et al. now report that TZD-stimulated macrophages release miR-690-containing vesicles that improve insulin sensitization and bypass unwanted side-effects.

AB - Thiazolidinediones (TZDs) are potent insulin-sensitizing drugs, but their use is accompanied by adverse side-effects. Rohm et al. now report that TZD-stimulated macrophages release miR-690-containing vesicles that improve insulin sensitization and bypass unwanted side-effects.

UR - https://www.scopus.com/pages/publications/85190305808

U2 - 10.1038/s42255-024-01030-x

DO - 10.1038/s42255-024-01030-x

M3 - Comment/Letter to the editor

C2 - 38605182

AN - SCOPUS:85190305808

VL - 6

SP - 785

EP - 786

JO - Nature metabolism

JF - Nature metabolism

IS - 5

ER -

Macrophage vesicles in antidiabetic drug action

Abstract

Access to Document

Other files and links

Fingerprint

Cite this